Pune Municipal Corporation areas see marginal improve in weekly Covid positivity, dying fee

0
62

With the easing of a number of COVID restrictions in Pune metropolis over the previous few weeks, PMC areas have seen a slight improve of their weekly positivity fee. Meanwhile, the dying fee has additionally elevated barely from 1.79 per cent to 1.8 per cent in every week.

The PMC recorded 2,110 new sufferers from July 2 to eight, up from 1,977 within the week of June 25 to July 1 and 1,729 within the week of June 18-24. The weekly positivity fee has elevated from 4.77 p.c within the week of June 18-24 to 4.89 p.c within the week of June 25- July 1, 5 p.c within the week of July 2-8.

A complete of 42 sufferers succumbed to the viral an infection from July 2 to eight, whereas 1,831 had been cured and a pair of,110 new circumstances had been reported. While 5 new circumstances of mucormycosis had been reported within the metropolis this week, there have been no deaths as a result of an infection.

Out of the whole 15 ward places of work, areas beneath 4 ward places of work reported greater than 200 new circumstances this week, with most 300 in Dhanakwadi-Sahakarnagar, 291 in Sinhagad Road, 240 in Hadapsar-Mundhwa and 200 in Aundh- Recorded in Baner.

Six ward places of work had greater than 100 new circumstances, whereas solely 5 ward places of work reported lower than 100 new circumstances, with Wanawadi-Ramtekdi recording the bottom variety of 39 circumstances.

As of Thursday, there have been a complete of two,941 lively sufferers in PMC areas, together with 1,447 in house isolation, 30 in COVID care facilities and 1,464 in varied hospitals within the metropolis, together with 617 in authorities hospitals and 847 in personal hospitals.

Of the 1,464 hospitalized sufferers, 409 had been on ventilator help, 279 in ICU and 454 on oxygen beds. According to the PMC, solely 9.65 per cent of the obtainable oxygen beds for Kovid sufferers in metropolis hospitals are at the moment stuffed.

.
With inputs from TheIndianEXPRESS

Leave a reply

Please enter your comment!
Please enter your name here